FolioObs › OLIN CORP (OLN) › Earnings calls

OLIN CORP earnings calls

OLN · every analyst question and management's answer

Oct 30, 2026 earnings call — Merger progress and third-quarter results

Olin expects to close the Huntsman merger in the first quarter of 2027 and expects more than $400 million of cost synergies.

Revenue $1.7B (est $1.8B) · EPS $0.13 (est $0.15)

Key quotes

"We remain confident in our ability to deliver more than $400 million of cost synergies and integration benefits and the planning we're doing now will help us make a fast start after closing."

— Kenneth Lane (CEO) · Merger integration

"As expected, we resumed normal operations at our Freeport VCM facility. Reduced operating rates resulted in approximately $30 million of negative impact."

— Kenneth Lane (CEO) · Chlor-alkali & VCM operations

"Winchester was awarded more than $1 billion in contracts during the quarter, approximately $600 million of which will be used to equip the new Lake City 6.8 millimeter ammunition facility."

— Kenneth Lane (CEO) · Winchester ammunition business

Analyst Q&A 15

Caustic soda price drivers

Q (Frank Mitsch · Fermium): They asked what has happened to caustic soda pricing in their system and what to expect next.

A: Management said caustic is a global market. Domestic prices improved slightly versus Q2, but exports are pressured by high Chinese exports and high freight costs. They expect seasonal lower production and demand now and possible tightening because market liquidity is reduced by freight issues.

"Domestically, we have seen prices improve slightly versus the second quarter." — Kenneth Lane (CEO)

Shintech contract and PVC options

Q (Joshua Spector · UBS): They asked how Olin plans to handle the Shintech contract in 2030 and whether they may need to build PVC capacity or line up partners.

A: Management said their vinyls strategy has not changed and they prefer to work with Shintech. If that does not happen, they have other options like selling VCM or pursuing PVC, but no decision yet. They expect to give a firmer update by the end of the third quarter next year.

"We have said all along that we believe that the best path forward is for both Shintech and Olin to continue to work together." — Kenneth Lane (CEO)

Merger synergy confidence ($400m)

Q (Hassan Ahmed · Alembic Global): They asked what is driving increased confidence in the $400 million synergy target and whether it can be exceeded.

A: Management said pre-close work is limited but clean teams are finding cost and efficiency opportunities. They have high confidence in $300 million of fixed-cost synergies and expect the $100 million chlorine supply item to occur in 2030. More detail will be provided on the first earnings call after closing.

"I have a very high level of confidence in the $300 million." — Kenneth Lane (CEO)

Chlorovinyls EBITDA year-over-year change

Q (Aleksey Yefremov · Barclays): They asked for a year-over-year bridge for chlorovinyls EBITDA and what major factors explain the change.

A: Management said a one-time $45V benefit from Q3 2025 did not recur this year. They also noted a hydrogen tax credit change that acted like a little over $25 million year-over-year penalty and a VCM production issue that was roughly a $32 million headwind. These one-time items masked other factors.

"The other thing is, you do know we had the VCM issue where we had to reduce rates really during almost all of the third quarter this year." — Todd Slater (CFO)

Chlorovinyl utilization rates Q4

Q (Jeffrey Zekauskas · JPMorgan): They asked if chlorovinyl utilization will change materially from Q3 to Q4.

A: Management said they do not expect a significant change in operating rates in Q4. They noted some planned and unplanned downtime and that Olin is operating below reported industry utilization, reflecting discipline and some turnarounds slipping into Q4. Overall, no big change expected.

"I would not expect the operating rates to change significantly." — Kenneth Lane (CEO)

VCM outage impact and Q4 destocking

Q (Salvator Tiano · KeyBanc): They asked whether the VCM outage impact becomes a Q4 tailwind and why Olin sees more severe Q4 destocking than others.

A: Management said Q4 seasonality is more accentuated and volatility is higher, so they reflected that in guidance. They confirmed the VCM plant ran at reduced rates for most of Q3, making the roughly $32 million impact a tailwind in Q4. They also warned chlor-alkali will face about a $25 million headwind from higher turnaround costs between Q3 and Q4.

"So that $32 million, yes, that's a tailwind in Q4." — Todd Slater (CFO)

Winchester demand and margins

Q (Patrick Cunningham · Citi): They asked about demand signals for Winchester, pricing power, and earnings outlook with military growth.

A: Management said Winchester has faced strong cost headwinds from metals and has been passing those costs through. Margins have improved but remain below historical levels, and the team is focused on cost control and efficiency, including at Lake City. Military demand is strong, but short-term earnings depend more on the commercial business.

"The military demand is going to continue to be strong, and that's very good to see." — Kenneth Lane (CEO)

Freight cost inflation effect

Q (Kevin McCarthy · Vertical): They asked whether freight cost inflation is a net benefit or a headwind for Olin overall.

A: Management said higher freight helped support pricing in Q2 but those benefits are now in the market and freight rates are backing up. Logistics costs are higher across truck and rail, so the company must focus on passing costs through via pricing or surcharges. Freight and logistics are an ongoing inflationary item to manage.

"So net-net, freight costs and cost of logistics is higher." — Kenneth Lane (CEO)

Caustic price assumptions in guidance

Q (Abigail Eberts · Wells Fargo): They asked if recent CMA caustic price moves match Olin's guidance assumptions or imply upside.

A: Management said they see the same market signals and spot prices are firming. Domestic pricing will follow with a lag, so more of the benefit is expected in the first quarter than Q4. That pattern supports the company's guidance.

"With the lag that you see in the market, we'll start to see more of that benefit in the first quarter than we're going to see here in the fourth quarter." — Kenneth Lane (CEO)

Cash use for synergies and litigation payments

Q (Matthew DeYoe · BofA): They asked whether Olin would use liquidity or debt to fund synergy capture and when the $100 million payment to Shintech impacted cash flow.

A: Management said synergy spend is expected later in the first 24 to 36 months and early synergies will not require large CapEx, so early spend should be modest. They will pursue high-return cases quickly. On legacy litigation, $114 million was spent through the end of Q3 and the remaining liability is not expected to be paid this year.

"Regarding your question on cash flow and the legacy litigation payments of $114 million, $114 million was spent through the end of the third quarter." — Todd Slater (CFO)

Global caustic capacity changes

Q (John Ezekiel Roberts · Mizuho): They asked how much global caustic capacity increased in 2026 and might increase in 2027.

A: Management said there has been a small capacity increase, but net of closures it may be a few hundred thousand tons in 2026, which they called a rounding error. They view the supply side as structurally favorable and said demand recovery will be the main driver of tighter markets. They remain optimistic on the industry outlook.

"There's been a little bit of increase in capacity, but net of closures, it may be a few hundred thousand tons in 2026." — Kenneth Lane (CEO)

$1B ammo contracts timing and Radford update

Q (Matthew Blair · TPH): They asked when the $1 billion in new ammo contracts will roll through and for an update on the Radford plant application.

A: Management said the second-source contract will roll through almost immediately as it continues existing supply. The equipping phase for the 6.8mm facility at Lake City will show more next year as equipment orders are placed. The Radford process has been slowed by the government and is on hold in the near term.

"That process has slowed, and that's been a decision by the government to slow that down." — Kenneth Lane (CEO)

China production effect on chlor-alkali

Q (Arun Viswanathan · RBC): They asked whether China increased production June–September, whether coal-based chlorine/caustic added supply, and if that will continue.

A: Management said Chinese carbide-based PVC ramped earlier and produced a lot of caustic that worked through the market. With higher energy prices filtering through, even carbide-based operations in China have cut rates, which should tighten caustic. They expect markets fairly stable into Q1 but with ongoing volatility and tightening into the new year.

"What we have seen over the past couple of months, though, is with the higher energy prices now beginning to filter through even in China, even the coal based, carbide-based PVC in China operating rates have been declining." — Kenneth Lane (CEO)

Beyond250 cost reductions next year

Q (Alek Ledvina · Truist): They asked how the $60 million to $80 million Beyond250 target for next year will be allocated across segments.

A: Management said Beyond250 is showing up in Epoxy with structural cost reductions and they expect $60 million to $80 million next year, and $110 million to $120 million this year. Manufacturing costs in CAPV are down mid-single digits, but some noise hides the benefit. Chlor-alkali remains the big piece to address in structural cost improvement.

"Chlor-alkali clearly is the remaining big piece for this year in that structural cost improvement." — Todd Slater (CFO)

China caustic export outlook

Q (David Begleiter · Deutsche Bank): They asked if consultant data underestimates China caustic exports and whether to expect a sharp reduction next year.

A: Management said exports stepped up in 2024 and stayed elevated in 2025, with another increment in 2026 that disrupted the market. They said China is effectively selling chlorine at negative values to subsidize exports and expressed skepticism that exports will drop sharply, while hoping the consultant forecast is right. Olin will focus on operating assets and selected export participation.

"And I will just say, I'll call spade a spade, they're paying people to take -- they're selling chlorine at negative values to subsidize that." — Kenneth Lane (CEO)

AI-generated notes on the earnings call transcript. Quotes are taken from the transcript. This is not a FolioObs investment view.

OLIN CORP (OLN) · Earnings calendar

Other earnings calls this week

  • GOOGL · ALPHABET INC — Gemini 4 models and Cloud TPU scaling
  • AMZN · AMAZON.COM INC — AWS AI growth and company results
  • MSFT · MICROSOFT CORP — Copilot expansion and AI-driven Azure growth
  • GOOG · ALPHABET INC-CL C — Gemini 4 launch and Cloud TPU scaling
  • V · VISA INC — Tokenization, VAS growth, and agentic commerce focus
  • MA · MASTERCARD INCORPORATED — Network expansion and agentic commerce push
  • SPGI · S&P GLOBAL INC — Strategic review of Capital IQ and data businesses
  • DASH · DOORDASH INC - A — Instacart deal and DashMart expansion

All of this week's earnings call summaries

FolioObs Features | 주요 기능

  • Dashboard — SEC 13F Portfolio Tracker, FolioObs 50 | 대시보드
  • AI Insights — Portfolio Analysis & Signals | AI 인사이트
  • Insider Trading — SEC Form 4 Tracker | 내부자 거래
  • Cathie Wood Today's Trades + AI Insights | 캐시 우드 오늘의 매매
  • ARK Invest Report — Daily Trades | ARK 리포트
  • Investment News — Data-Driven Updates | 뉴스
  • Weekly Report — Market Movers | 주간 리포트
  • How to Read a 13F — 5-Minute Guide | 13F 읽는 법
  • The FolioObs 50 — All Tracked Investors | FolioObs 50 전체 보기
  • Wall Street Consensus — Shared Holdings | 월가 컨센서스
  • US Politician Trades — STOCK Act | 정치인 매매 추적
  • Earnings Calendar | 실적 발표 캘린더
  • This Week's Earnings Call Summaries | 이번 주 어닝콜 한 줄 요약

FolioObs 50 | 추적 중인 월가 투자자 50인

  • Warren Buffett — Berkshire Hathaway | 워렌 버핏
  • Cathie Wood — ARK Invest | 캐시 우드
  • Stanley Druckenmiller — Duquesne Family Office | 스탠리 드러켄밀러
  • Ray Dalio — Bridgewater Associates | 레이 달리오
  • George Soros — Soros Fund Management | 조지 소로스
  • Bill Ackman — Pershing Square Capital | 빌 애크먼
  • David Tepper — Appaloosa Management | 데이비드 테퍼
  • Chase Coleman — Tiger Global Management | 체이스 콜먼
  • Dan Loeb — Third Point | 댄 로엡
  • Seth Klarman — Baupost Group | 세스 클라만
  • National Pension Service (NPS) — Korea National Pension Service | 국민연금
  • David Einhorn — Greenlight Capital | 데이비드 아인혼
  • John Paulson — Paulson & Co | 존 폴슨
  • Howard Marks — Oaktree Capital Management | 하워드 막스
  • Leon Cooperman — Omega Family Office | 레온 쿠퍼먼
  • Ken Griffin — Citadel | 켄 그리핀
  • Steve Cohen — Point72 Asset Management | 스티브 코헨
  • Li Lu — Himalaya Capital | 리 루
  • Mohnish Pabrai — Pabrai Investment Funds | 모니시 파브라이
  • Bruce Berkowitz — Fairholme Capital Management | 브루스 버코비츠
  • Nelson Peltz — Trian Fund Management | 넬슨 펠츠
  • Carl Icahn — Icahn Capital | 칼 아이칸
  • Paul Singer — Elliott Management | 폴 싱어
  • Philippe Laffont — Coatue Management | 필립 라퐁
  • Andreas Halvorsen — Viking Global | 안드레아스 할보르센
  • Daniel Sundheim — D1 Capital | 다니엘 선드하임
  • Masayoshi Son — SoftBank Group | 손정의
  • Terry Smith — Fundsmith | 테리 스미스
  • Joel Greenblatt — Gotham Asset Management | 조엘 그린블랫
  • Bill Miller — Miller Value Partners | 빌 밀러
  • Brad Gerstner — Altimeter Capital | 브래드 거스트너
  • Rajiv Jain — GQG Partners | 라지브 자인
  • Duan Yongping — H&H International | 돤융핑
  • Chris Hohn — TCI Fund Management | 크리스 혼
  • Stephen Mandel — Lone Pine Capital | 스티븐 만델
  • Prem Watsa — Fairfax Financial | 프렘 왓사
  • Sequoia Fund — Ruane Cunniff & Goldfarb | 세쿼이아 펀드
  • Guy Spier — Aquamarine Capital | 가이 스파이어
  • Lee Ainslie — Maverick Capital | 리 아인슬리
  • David Abrams — Abrams Capital | 데이비드 아브람스
  • Pat Dorsey — Dorsey Asset Management | 팻 도시
  • Dev Kantesaria — Valley Forge Capital | 데브 칸테사리아
  • Francois Rochon — Giverny Capital | 프랑수아 로숑
  • Thomas Russo — Gardner Russo & Quinn | 토마스 루소
  • Tweedy Browne — Tweedy Browne | 트위디 브라운
  • Temasek — Temasek Holdings | 테마섹
  • Saudi PIF — Public Investment Fund | 사우디 국부펀드
  • Baillie Gifford — Baillie Gifford | 베일리 기포드
  • Ron Baron — Baron Capital | 론 배런
  • Thomas Gayner — Markel Group | 토마스 게이너